Covered recipient · General Payments record
KATRINA SLAUGHTER WADE
Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecologic Oncology
General Payments · PY2018–2024
$6,915.46
- Reported across 40 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,175.00 | 1 |
| Food and Beverage | $363.59 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $2,325.23 | 4 |
| ABBVIE INC. | $83.29 | 1 |
| Merck Sharp & Dohme Corporation | $55.28 | 2 |
| Tempus AI, Inc | $29.67 | 1 |
| Acerta Pharma LLC | $24.11 | 1 |
| Myriad Genetic Laboratories, Inc. | $21.01 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $83.29 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106294904 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.11 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105401193 | CMS |
| GlaxoSmithKline, LLC. | $4.47 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116455739 | CMS |
| GlaxoSmithKline, LLC. | $2,175.00 | 06/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116323364 | CMS |
| GlaxoSmithKline, LLC. | $119.52 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116587367 | CMS |
| GlaxoSmithKline, LLC. | $26.24 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116670486 | CMS |
| Merck Sharp & Dohme LLC | $26.81 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141718668 | CMS |
| Merck Sharp & Dohme LLC | $28.47 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141876845 | CMS |
| Myriad Genetic Laboratories, Inc. | $21.01 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152541971 | CMS |
| Tempus AI, Inc | $29.67 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150176681 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.